Literature DB >> 3102392

A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth.

D C Bennett, P J Cooper, I R Hart.   

Abstract

An immortal line of pigmented melanocytes, "melan-a", has been derived from normal epidermal melanoblasts from embryos of inbred C57BL mice. The conditions favouring proliferation of these cells largely resemble those for normal, non-established mouse melanoblasts and melanocytes, and include a low extracellular pH and the presence of a tumour promoter, tetradecanoyl phorbol acetate (TPA) or teleocidin. Melan-a cells have the diploid chromosome number and do not form tumours in syngeneic or nude mice. They are therefore the first known line of non-tumorigenic mouse melanocytes, although an aneuploid melanocyte line of untested tumorigenicity has been reported (Sato et al., 1985). Melan-a cells are syngeneic with the B16 melanoma and its sublines, and provide an excellent parallel non-tumorigenic line for studies of the cellular and molecular basis of melanoma malignancy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102392     DOI: 10.1002/ijc.2910390324

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  154 in total

1.  Structure-function analysis of VPS9-ankyrin-repeat protein (Varp) in the trafficking of tyrosinase-related protein 1 in melanocytes.

Authors:  Kanako Tamura; Norihiko Ohbayashi; Koutaro Ishibashi; Mitsunori Fukuda
Journal:  J Biol Chem       Date:  2010-12-26       Impact factor: 5.157

2.  Proton pump inhibitors decrease melanogenesis in melanocytes.

Authors:  Seung-Hwa Baek; Sang-Han Lee
Journal:  Biomed Rep       Date:  2015-07-17

3.  Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes.

Authors:  Alexander C Theos; Danièle Tenza; José A Martina; Ilse Hurbain; Andrew A Peden; Elena V Sviderskaya; Abigail Stewart; Margaret S Robinson; Dorothy C Bennett; Daniel F Cutler; Juan S Bonifacino; Michael S Marks; Graça Raposo
Journal:  Mol Biol Cell       Date:  2005-09-14       Impact factor: 4.138

4.  Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r.

Authors:  Elodie Le Pape; Thierry Passeron; Alessio Giubellino; Julio C Valencia; Rainer Wolber; Vincent J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

5.  The GTPase-deficient Rab27A(Q78L) mutant inhibits melanosome transport in melanocytes through trapping of Rab27A effector protein Slac2-a/melanophilin in their cytosol: development of a novel melanosome-targetinG tag.

Authors:  Morié Ishida; Saki P Arai; Norihiko Ohbayashi; Mitsunori Fukuda
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

6.  Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter.

Authors:  S Carreira; T J Dexter; U Yavuzer; D J Easty; C R Goding
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome.

Authors:  Duarte C Barral; José S Ramalho; Ross Anders; Alistair N Hume; Holly J Knapton; Tanya Tolmachova; Lucy M Collinson; David Goulding; Kalwant S Authi; Miguel C Seabra
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  The mouse organellar biogenesis mutant buff results from a mutation in Vps33a, a homologue of yeast vps33 and Drosophila carnation.

Authors:  Tamio Suzuki; Naoki Oiso; Rashi Gautam; Edward K Novak; Jean-Jacques Panthier; P G Suprabha; Thomas Vida; Richard T Swank; Richard A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

9.  Expression and function of CD9 in melanoma cells.

Authors:  Jun Fan; Guo-Zhang Zhu; Richard M Niles
Journal:  Mol Carcinog       Date:  2010-01       Impact factor: 4.784

10.  Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.

Authors:  Tatiana I Ricca; Gangning Liang; Ana Paula M Suenaga; Sang W Han; Peter A Jones; Miriam G Jasiulionis
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.